Molecular interaction and localization of tocotrienol-rich fraction (TRF) within the matrices of lipid nanoparticles: Evidence studies by Differential Scanning Calorimetry (DSC) and Proton Nuclear Magnetic Resonance spectroscopy (1H NMR)

被引:47
作者
Ali, Hazem [1 ]
El-Sayed, Khalid [1 ]
Sylvester, Paul W. [1 ]
Nazzal, Sami [1 ]
机构
[1] Univ Louisiana Monroe, Coll Pharm, Dept Basic Pharmaceut Sci, Monroe, LA 71201 USA
关键词
Nanostructured lipid carriers; Solid lipid nanoparticles; Proton Nuclear Magnetic Resonance; Differential Scanning Calorimetry; Tocotrienol; MAMMARY EPITHELIAL-CELLS; ELECTRON-MICROSCOPY; BINARY-MIXTURES; CARRIER SYSTEM; SOLID LIPIDS; DRUGS; TOCOPHEROLS; ENTRAPMENT; SLN(TM); RELEASE;
D O I
10.1016/j.colsurfb.2010.02.003
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Nanostructured lipid carriers (NLCs), made from mixtures of solid and liquid lipids, were postulated to have superior properties over solid lipid nanoparticles (SLNs). Nonetheless, the architecture of their inner cores remains elusive. The objective of this study was to elucidate the mode by which tocotrienol-rich fraction (TRF) is entrapped within NLCs and the impact of TRF interaction with solid lipids on the long-term stability of the nanoparticles. The mode of TRF localization was postulated from TEM image analysis and H-1 NMR signals' amplitude. The size, polydispersity, and fusion enthalpy were found to decrease with an increase in TRF loading, which implied a distortion in the crystallinity of the nanoparticles and the preferential entrapment of TRF within the cores of the NLCs. Nonetheless, H-1 NMR spectra of TRF-NLCs broadened as TRF load decreased from 100 to 10%, which was attributed to partial TRF mobility on the surface of the nanoparticles. This was confirmed by TEM images of NLCs at 50% TRF loads. These data led to the conclusion that NLCs have limited capacity to accommodate TRF with the excess being expelled to the surface of the nanoparticles. Such arrangement may have implication on future utility of the NLCs as drug delivery vehicles. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:286 / 297
页数:12
相关论文
共 33 条
[1]   Diazepam-Loaded Solid Lipid Nanoparticles: Design and Characterization [J].
Abdelbary, Ghada ;
Fahmy, Rania H. .
AAPS PHARMSCITECH, 2009, 10 (01) :211-219
[2]  
Ahlin P., 1998, ACTA PHARM, V48, P257
[3]   Development and validation of a reversed-phase HPLC method for the simultaneous analysis of simvastatin and tocotrienols in combined dosage forms [J].
Ali, Hazem ;
Nazzal, Sami .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 49 (04) :950-956
[4]   ONE-DIMENSIONAL AND 2-DIMENSIONAL H-1-NUCLEAR AND C-13-NUCLEAR MAGNETIC-RESONANCE (NMR) ANALYSIS OF VITAMIN-E RAW-MATERIALS OR ANALYTICAL REFERENCE-STANDARDS [J].
BAKER, JK ;
MYERS, CW .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :763-770
[5]   Crystallization tendency and polymorphic transitions in triglyceride nanoparticles [J].
Bunjes, H ;
Westesen, K ;
Koch, MHJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 129 (1-2) :159-173
[6]   Incorporation of the model drug ubidecarenone into solid lipid nanoparticles [J].
Bunjes, H ;
Drechsler, M ;
Koch, MHJ ;
Westesen, K .
PHARMACEUTICAL RESEARCH, 2001, 18 (03) :287-293
[7]   Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering [J].
Bunjes, Heike ;
Unruh, Tobias .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (06) :379-402
[8]   Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry [J].
Castelli, F ;
Puglia, C ;
Sarpietro, MG ;
Rizza, L ;
Bonina, F .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 304 (1-2) :231-238
[9]   Solid lipid nanoparticles as delivery systems for bromocriptine [J].
Esposito, Elisabetta ;
Fantin, Martina ;
Marti, Matteo ;
Drechsler, Markus ;
Paccamiccio, Lydia ;
Mariani, Paolo ;
Sivieri, Elisa ;
Lain, Francesco ;
Menegatti, Enea ;
Morari, Michele ;
Cortesi, Rita .
PHARMACEUTICAL RESEARCH, 2008, 25 (07) :1521-1530
[10]   Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase [J].
Freitas, C ;
Müller, RH .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 47 (02) :125-132